Showing results (1721-1730 of 2,048) with videos related to
Sort By:
Pageof 205
Science Advances|March 26, 2025
Assessing cancer therapeutic efficacy in vivo using [<sup>2</sup>H<sub>7</sub>]glucose deuterium metabolic imagingMario C Chang, Vinay R Malut, Rohit Mahar, et al.Radiation Oncology (London, England)|March 19, 2013
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceLeonard N Chen, Simeng Suy, Sunghae Uhm, et al.American Heart Journal|August 6, 2023
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and designZachary L Cox, Hasan K Siddiqi, Lynne W Stevenson, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 11, 2016
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working GroupSean P Collins, Phillip D Levy, Jennifer L Martindale, et al.MMWR. Morbidity and Mortality Weekly Report|October 6, 2022
Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016-2021Jennifer P Collins, Hazel J Shah, Daniel Lowell Weller, et al.Heart Failure Reviews|September 2, 2025
Hypertensive acute heart failure: a critical perspective on definition, epidemiology, pathophysiology, and prognosis-a narrative review: a joint session with the Romanian Society of Cardiology (part II)Oliviana Geavlete, Sean P Collins, Alexandre Mebazaa, et al.Blood Advances|August 31, 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trialChristopher P Fox, Ayesha S Ali, Graham McIlroy, et al.The Lancet. Oncology|April 6, 2019
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trialAndrew Davies, Thomas E Cummin, Sharon Barrans, et al.American Heart Journal|March 3, 2015
Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulatorsJaved Butler, Gregg C Fonarow, Christopher O'Connor, et al.International Journal of Radiation Oncology, Biology, Physics|July 6, 2019
Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation TherapyNaomi Y Jiang, Audrey T Dang, Ye Yuan, et al.Pageof 205